Barrow Robert
SEC CIK 1897557 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DFTX | Definium Therapeutics, Inc. | CEO, Dir | 2.24M | $6,215 | $4.26M | 42 | 2022-01-15 | 2026-09-14 |
Most active insiders at DFTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barrow Robert | CEO, Dir | — | $3.08M |
| 2 | Sullivan Mark | CLO | — | $1.04M |
| 3 | Karlin Daniel | Chief Medical Off | — | $748.9K |
| 4 | Roberts Brandi | CFO | — | $135.7K |
| 5 | Wiley Matthew T. | Chief Commercial Off | — | $129.1K |
| 6 | Adsett Roger | Dir | — | — |
| 7 | CRYSTAL ROGER | Dir | — | — |
| 8 | Bruhn Suzanne Louise | Dir | — | — |
| 9 | Krebs Andreas | Dir | — | — |
| 10 | Vallone Carol A | Dir | — | — |
Transactions 42
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 08:30 | 2026-09-14 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | A - Grant | $0.00 | +750.0K | 2.24M | +50% | $0 | |
| T | 2026-09-04 21:30 | 2026-09-02 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | A - Grant | $0.00 | +40.0K | 1.51M | +3% | $0 |
| T | 2026-09-04 21:30 | 2026-09-03 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $37.94 | -19.0K | 1.49M | -1% | -$721.7K |
| 2026-08-12 08:30 | 2026-08-12 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | A - Grant | $0.00 | +375.0K | 1.47M | +34% | $0 | |
| T | 2026-06-26 16:30 | 2026-06-25 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $45.03 | -29.2K | 1.10M | -3% | -$1.32M |
| 2026-06-22 09:45 | 2026-06-22 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | A - Grant | $0.00 | +375.0K | 1.13M | +50% | $0 | |
| T | 2026-03-26 | 2026-03-25 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $18.47 | -24.4K | 752.5K | -3% | -$451.2K |
| 2026-02-05 | 2026-02-03 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | A - Grant | $0.00 | +320.0K | 1.10M | +41% | $0 | |
| T | 2025-12-29 | 2025-12-26 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $13.15 | -25.8K | 778.5K | -3% | -$339.2K |
| T | 2025-09-26 | 2025-09-25 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $9.77 | -25.8K | 804.3K | -3% | -$252.0K |
| T | 2025-06-26 | 2025-06-25 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $6.80 | -26.5K | 830.1K | -3% | -$180.1K |
| T | 2025-03-26 | 2025-03-25 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $6.74 | -21.2K | 856.6K | -2% | -$142.9K |
| 2025-03-13 | 2025-03-12 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | A - Grant | $0.00 | +350.0K | 877.8K | +66% | $0 | |
| 2024-12-27 | 2024-12-26 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $7.43 | -19.1K | 526.7K | -4% | -$142.0K | |
| T | 2024-09-25 | 2024-09-25 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $5.98 | -19.8K | 545.8K | -3% | -$118.2K |
| M | 2024-08-20 | 2024-08-19+ | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | P - Purchase | $6.21 | +1,000 | 565.5K | +0.2% | +$6,215 |
| T | 2024-06-25 | 2024-06-25 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $7.22 | -15.7K | 564.5K | -3% | -$113.1K |
| T | 2024-03-26 | 2024-03-25 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $9.50 | -16.5K | 580.2K | -3% | -$156.9K |
| 2023-12-26 | 2023-12-26 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $3.63 | -13.2K | 596.7K | -2% | -$48.1K | |
| M | 2023-09-25 | 2023-09-25 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $3.58 | -13.5K | 611.7K | -2% | -$48.3K |
| M | 2023-06-27 | 2023-06-27 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $3.20 | -15.5K | 623.5K | -2% | -$49.6K |
| 2023-03-17 | 2023-03-14 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | A - Grant | $0.00 | +400.0K | 639.0K | +167% | $0 | |
| 2023-03-02 | 2023-03-01 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $3.51 | -8,273 | 239.0K | -3% | -$29.0K | |
| 2022-12-22 | 2022-12-21 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $2.69 | -3,861 | 247.2K | -2% | -$10.4K | |
| 2022-10-25 | 2022-10-25 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $2.81 | -1,207 | 251.1K | -0.5% | -$3,392 | |
| 2022-10-18 | 2022-10-18 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $3.11 | -1,220 | 252.3K | -0.5% | -$3,794 | |
| 2022-09-27 | 2022-09-26 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $5.51 | -1,264 | 253.5K | -0.5% | -$6,965 | |
| 2022-09-19 | 2022-09-16 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $7.26 | -1,350 | 254.8K | -0.5% | -$9,801 | |
| 2022-09-01 | 2022-08-31 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $11.67 | -1,228 | 256.1K | -0.5% | -$14.3K | |
| 2022-08-17 | 2022-08-16 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $0.68 | -20.4K | 3.86M | -0.5% | -$13.8K | |
| 2022-07-26 | 2022-07-25 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $0.69 | -18.7K | 3.88M | -0.5% | -$12.9K | |
| 2022-07-18 | 2022-07-18 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $0.7 | -19.4K | 3.90M | -0.5% | -$13.6K | |
| 2022-06-28 | 2022-06-27 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $0.7 | -36.8K | 3.92M | -0.9% | -$25.7K | |
| 2022-06-21 | 2022-06-16 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $0.7 | -21.3K | 3.96M | -0.5% | -$14.9K | |
| 2022-05-26 | 2022-05-25 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $0.77 | -18.4K | 3.98M | -0.5% | -$14.2K | |
| A | 2022-05-19 | 2022-05-18 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | S - Sale | $0.71 | -18.9K | 4.00M | -0.5% | -$13.5K |
| 2022-05-17 | 2022-05-15 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | F - Tax | $0.82 | -18.9K | 4.00M | -0.5% | -$15.5K | |
| 2022-04-19 | 2022-04-18 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | F - Tax | $0.92 | -19.1K | 4.01M | -0.5% | -$17.6K | |
| D | 2022-03-28 | 2022-03-24 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | A - Grant | $0.00 | +1.82M | 4.03M | +82% | $0 |
| 2022-03-17 | 2022-03-15 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | F - Tax | $1.00 | -12.6K | 2.21M | -0.6% | -$12.6K | |
| 2022-02-17 | 2022-02-15 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | F - Tax | $1.35 | -18.7K | 2.23M | -0.8% | -$25.3K | |
| 2022-01-19 | 2022-01-15 | DFTX | Definium Therapeutics, Inc. | Barrow Robert | CEO, Dir | F - Tax | $1.05 | -190.3K | 2.24M | -8% | -$199.8K |
Purchase Sale Sale after option exercise All abbreviations